— Sameer Paranjpe
ALACHUA, FLORIDA, USA, January 19, 2023 /EINPresswire.com/ — NovaBone, the chief in biologic medical gadgets, has named Sameer Paranjpe as its new Vice President of Analysis and Improvement. On this position, Paranjpe might be accountable for overseeing the corporate’s analysis and improvement efforts, in addition to driving innovation and improvement of recent merchandise for NovaBone.
Paranjpe has greater than 17 years of management, challenge administration, and product improvement expertise within the biotechnology and medical machine industries. He has efficiently initiated and led massive engagements and PMOs for each non-public and publicly traded organizations, specializing in tasks involving not solely analysis and improvement but additionally operational, medical, and regulatory initiatives.
“Sameer is a forward-thinking, collaborative chief with a formidable monitor report of nurturing revolutionary new biotech merchandise from ideation to profitable launch,” stated Brian Carlisle, CEO of NovaBone. “His expertise and result-oriented method will add vital worth to our management group as we proceed to seek out new methods to enhance the well being and lives of the sufferers we serve,” Carlisle added that Paranjpe may even function a member of the Board of Administrators for NovaBone.
“I’m excited to hitch the NovaBone group and assist additional the group’s vital mission to develop biomaterials that harness the physique’s pure therapeutic course of,” stated Paranjpe. “NovaBone is targeted on biotechnology that makes use of the physique’s personal regenerative capabilities to assist the work of surgeons. That’s the way forward for orthopedic drugs.”
Sameer Paranjpe has gained quite a few awards over the previous decade for excellence in analysis and improvement. He holds grasp’s and undergraduate levels in Mechanical Engineering from the College of Florida and the College of Mumbai, respectively.
NovaBone, a Halma firm, is privately held and based mostly in Florida since 2002. NovaBone developed the primary bioactive artificial bone graft provided to the orthopedic neighborhood and has lengthy been on the forefront of bioactive glass bone graft gadgets. It has developed quite a few formulations and supply techniques of its patented, bioactive expertise platform that leads to accelerated bone development. In complete, their completely formulated bone graft substitute has been used for the restore of osseous defects all through the skeletal system for over a decade and utilized in over 1,000,000 medical functions with unparalleled success validating the security and efficacy of NovaBone’s expertise.